• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Poll

POLL: Which Most Recent FDA Approval Are You Excited About?

Click here to answer this week's poll.

Which Most Recent FDA Approval Are You Excited About?

Sirolimus topical gel 0.2% for facial angiofibromas with tuberous sclerosis complex
Ruxolitinib cream 1.5% for nonsegmental vitiligo
Baricitinib for alopecia areata
Roflumilast cream 0.3% for plaque psoriasis
Ustekinumab for pediatric psoriatic arthritis
Hyaluronic acid filler for loss of jawline definition

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.